Product Added to Cart!
$25.80

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI05036_5_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
Boc-nortropinone
Brand Name
Chem Impex
Product Number
05036
CAS
185099-67-6
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
2794767
IUPAC Name
tert-butyl 3-oxo-8-azabicyclo3.2.1octane-8-carboxylate
InChI Key
MENILFUADYEXNU-UHFFFAOYSA-N
SMILES
CC(C)(C)OC(=O)N1C2CCC1CC(=O)C2

Description

Boc-nortropinone is widely utilized in research focused on

Synthetic Chemistry: This compound serves as a key intermediate in the synthesis of various alkaloids and pharmaceuticals, enabling researchers to develop new drugs with enhanced efficacy.

Drug Development: Its unique structure allows for modifications that can lead to the creation of novel therapeutic agents, particularly in the treatment of neurological disorders.

Analytical Chemistry: Boc-nortropinone is used as a standard in chromatographic techniques, helping researchers ensure the accuracy of their analytical results.

Material Science: This chemical is explored for its potential applications in the development of advanced materials, including polymers that exhibit unique properties.

Biochemistry: It plays a role in the study of enzyme mechanisms and interactions, providing insights that can lead to breakthroughs in biocatalysis.

References Data Source From Pubchem

Multistep Synthesis and Nematicidal Activity of 2-(8-azabicyclo[3.2.1]octan-3-yl)-3-imino-2,3-dihydro-1H-isoindol-1-One Derivatives

Publication Name: Chemistry of Heterocyclic Compounds
Publication Date: 2021-01
DOI: 10.1007/s10593-021-02864-z

Functional Group Interconversion of Alkylidenemalononitriles to Primary Alcohols by a Cooperative Redox Operation

Publication Name: Synthesis
Publication Date: 2020-07-21
DOI: 10.1055/s-0040-1707184

Synthesis and in vitro cytotoxic evaluation of novel diazaspiro bicyclo hydantoin derivatives in human leukemia cells: A SAR study

Publication Name: Investigational New Drugs
Publication Date: 2008-10-07
DOI: 10.1007/s10637-008-9179-3